Neil R. Cashman

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Neuroscience Biology, Medicine and Surgery
Google:
"Neil Cashman"
Mean distance: 53433
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McAlary L, Yerbury JJ, Cashman NR. (2020) The prion-like nature of amyotrophic lateral sclerosis. Progress in Molecular Biology and Translational Science. 175: 261-296
Plotkin SS, Cashman NR. (2020) Passive immunotherapies targeting Aβ and tau in Alzheimer's disease. Neurobiology of Disease. 105010
Wright GSA, Watanabe TF, Amporndanai K, et al. (2020) Purification and Structural Characterization of Aggregation-Prone Human TDP-43 Involved in Neurodegenerative Diseases. Iscience. 23: 101159
Khorvash M, Blinov N, Ladner-Keay C, et al. (2020) Molecular interactions between monoclonal oligomer-specific antibody 5E3 and its amyloid beta cognates. Plos One. 15: e0232266
Semmler S, Gagné M, Garg P, et al. (2020) TNF receptor associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation. The Journal of Biological Chemistry
Crown A, McAlary L, Fagerli E, et al. (2020) Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection. Plos One. 15: e0227655
McAlary L, Plotkin SS, Yerbury JJ, et al. (2019) Corrigendum: Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience. 12: 311
McAlary L, Plotkin SS, Yerbury JJ, et al. (2019) Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience. 12: 262
McAlary L, Plotkin SS, Cashman NR. (2019) Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases. Cns Drugs
Zhao B, Marciniuk K, Gibbs E, et al. (2019) Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1. Vaccine
See more...